Adroit Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.90 M
as on 24-10-2024
- Company Age 47 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.13 Cr
as on 24-10-2024
- Satisfied Charges ₹ 16.36 Cr
as on 24-10-2024
- Revenue 2.58%
(FY 2023)
- Profit -6.07%
(FY 2023)
- Ebitda 1.44%
(FY 2023)
- Net Worth 17.35%
(FY 2023)
- Total Assets 22.26%
(FY 2023)
About Adroit Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹38.13 Cr. The company has closed loans amounting to ₹16.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhupendra Kukreja, Sanjay Cheturam, Ghanshyamdas Kukreja, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH1977PTC019620
- Company No.
019620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 1977
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adroit Pharmaceuticals Private Limited offer?
Adroit Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Disinfectant Chemicals, Sodium Hypochlorite, Alcohol Solvents, Surgical Spirit, Antipyretic Medication, Paracetamol Syrup.
Who are the key members and board of directors at Adroit Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupendra Kukreja  | Director | 10-Mar-1997 | Current |
| Sanjay Cheturam | Director | 10-Mar-1997 | Current |
| Ghanshyamdas Kukreja | Director | 19-Oct-1981 | Current |
| Cheturam Kukreja | Director | 19-Oct-1981 | Current |
| Abhimanyu Kukreja | Director | 24-Apr-1979 | Current |
Financial Performance and Corporate Structure Insights of Adroit Pharmaceuticals.
Adroit Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.58% increase. The company also saw a slight decrease in profitability, with a 6.07% decrease in profit. The company's net worth Soared by an impressive increase of 17.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adroit Pharmaceuticals?
In 2023, Adroit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Household Pharmaceuticals LimitedActive 30 years 9 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Haseeb Pharmaceuticals Private LimitedActive 25 years 8 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Heil German Pharmaceuticals Private LimitedActive 14 years 1 month
Bhupendra Kukreja and Sanjay Cheturam are mutual person
- Leela Organics Private LimitedActive 4 years 2 months
Bhupendra Kukreja and Sanjay Cheturam are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2022 | ₹15.00 Cr | Open |
Axis Bank Limited Creation Date: 16 Sep 2021 | ₹20.55 Cr | Open |
Others Creation Date: 20 Jun 2020 | ₹3.00 M | Open |
How Many Employees Work at Adroit Pharmaceuticals?
Adroit Pharmaceuticals has a workforce of 52 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adroit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
